Weight-Loss Drug Ads Take Over the Super Bowl as Pharma Embraces Direct-to-Consumer Marketing 
Sony Q3 Profit Jumps on Gaming and Image Sensors, Full-Year Outlook Raised 
Missouri Judge Dismisses Lawsuit Challenging Starbucks’ Diversity and Inclusion Policies 
Samsung Electronics Shares Jump on HBM4 Mass Production Report 
SpaceX Prioritizes Moon Mission Before Mars as Starship Development Accelerates 
Alphabet’s Massive AI Spending Surge Signals Confidence in Google’s Growth Engine 
Prudential Financial Reports Higher Q4 Profit on Strong Underwriting and Investment Gains 
Nvidia, ByteDance, and the U.S.-China AI Chip Standoff Over H200 Exports 
Kroger Set to Name Former Walmart Executive Greg Foran as Next CEO 
Baidu Approves $5 Billion Share Buyback and Plans First-Ever Dividend in 2026 
Nvidia CEO Jensen Huang Says AI Investment Boom Is Just Beginning as NVDA Shares Surge 
SoftBank Shares Slide After Arm Earnings Miss Fuels Tech Stock Sell-Off 
American Airlines CEO to Meet Pilots Union Amid Storm Response and Financial Concerns 
Rio Tinto Shares Hit Record High After Ending Glencore Merger Talks 
FDA Targets Hims & Hers Over $49 Weight-Loss Pill, Raising Legal and Safety Concerns 
DBS Expects Slight Dip in 2026 Net Profit After Q4 Earnings Miss on Lower Interest Margins 
Once Upon a Farm Raises Nearly $198 Million in IPO, Valued at Over $724 Million 
SAN FRANCISCO, Aug. 22, 2017 -- Hagens Berman Sobol Shapiro LLP reminds investors in TechnipFMC plc (NYSE:FTI) of the October 2, 2017 Lead Plaintiff deadline in the pending securities class action.
If you purchased or otherwise acquired securities of FTI between April 27, 2017 and July 24, 2017 and suffered losses contact Hagens Berman Sobol Shapiro LLP. For more information visit:
https://www.hbsslaw.com/cases/FTI
or contact Reed Kathrein, who is leading the firm’s investigation, by calling 510-725-3000 or emailing [email protected].
On July 24, 2017, FTI announced in its Form 8-K filed with the U.S. Securities and Exchange Commission that it would restate certain unaudited interim condensed consolidated U.S. GAAP financial statements. Specifically, FTI determined that it would restate financial statements for March 31, 2017 and for the three months ended March 31, 2017 included in the Company’s quarterly report on Form 10-Q, previously filed with the SEC on May 4, 2017.
The Company explained “net income attributable to the Company in the quarter ending March 31, 2017 was overstated by $209.5 million ($0.45 per share).”
This news drove the price of FTI shares down on unusually heavy volume on July 25, 2017.
Recently, on August 4, 2017, FTI filed its amended Form 10-Q for the quarterly period ended March 31, 2017. Defendants reduced previously reported net income attributable to TechnipFMC from $190.8 million to a net loss of $18.7 million for that period.
“We’re focused on the magnitude of management’s improper accounting that, as corrected, wipes out previously reported Q1 2017 net income,” said Hagens Berman partner Reed Kathrein.
Whistleblowers: Persons with non-public information regarding FTI should consider their options to help in the investigation or take advantage of the SEC Whistleblower program. Under the new SEC whistleblower program, whistleblowers who provide original information may receive rewards totaling up to 30 percent of any successful recovery made by the SEC. For more information, call Reed Kathrein at 510-725-3000 or email [email protected].
About Hagens Berman
Hagens Berman is a national investor-rights law firm headquartered in Seattle, Washington with offices in 10 cities. The Firm represents investors, whistleblowers, workers and consumers in complex litigation. More about the Firm and its successes can be found at www.hbsslaw.com. For the latest news visit our newsroom or follow us on Twitter at @classactionlaw.
Contact: Reed Kathrein, 510-725-3000
